Carson Wealth (CWM LLC)’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$814 Sell
455
-115
-20% -$244 ﹤0.01% 5425
2025
Q4
$1K Sell
570
-684
-55% -$1.8K ﹤0.01% 5267
2025
Q3
$4K Sell
1,254
-16,397
-93% -$43.6K ﹤0.01% 4839
2025
Q2
$10K Buy
17,651
+12,115
+219% +$9.43K ﹤0.01% 4305
2025
Q1
$5K Buy
5,536
+4,686
+551% +$6.5K ﹤0.01% 4477
2024
Q4
$1K Sell
850
-270
-24% -$487 ﹤0.01% 4776
2024
Q3
$2K Buy
1,120
+976
+678% +$2.22K ﹤0.01% 4447
2024
Q2
$0 Buy
144
+129
+860% +$346 ﹤0.01% 4867
2024
Q1
$0 Buy
+15
New +$22 ﹤0.01% 4660

Other funds holding PROK

Carson Wealth (CWM LLC)'s PROK Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its ProKidney (PROK) stake by 20% in Q1 2026, selling an estimated $244 and leaving 455 shares worth $814. The position accounts for ﹤0.01% of the portfolio, ranked #5425.

Carson Wealth (CWM LLC) first reported a position in PROK in Q1 2024 and has held it in 9 quarters since. The position peaked at $10K in Q2 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Carson Wealth (CWM LLC) held 455 shares of ProKidney worth $814 as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 115 ProKidney shares in Q1 2026, an estimated $244.
  • ProKidney made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5425 holding.
  • Carson Wealth (CWM LLC) first reported a position in ProKidney in Q1 2024 and has held it in 9 quarters since.
  • Carson Wealth (CWM LLC)'s ProKidney position peaked at $10K in Q2 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.